In 1979, Ridley Scott took a trip into a nightmarish region of space (fuelled by the real nightmares of H.R. Giger) and returned with a petrified crew and an extra passenger they'd rather not have ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Health Catalyst (HCAT) on Wednesday announced that Ben Albert, its president and chief operating officer, has been named as the company’s new chief executive and a member of the board, effective Feb.

Idaho National Laboratory (INL) has teamed up with artificial intelligence (AI) computing giant NVIDIA to advance “PROMETHEUS,” INL’s first-of-its-kind demonstration of an autonomous nuclear reactor ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer waited two years ...

The science-fiction thriller Prometheus is streaming on Netflix from today (16 February 2026). The movie follows a crew of a deep-space research vessel as they travel to a distant moon after ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Women exited the U.S. labor force in record numbers in 2025. A new national survey by the ...

From the moment 4-year-old Cameron first stepped out into Glimmer in Spyro 2, he knew video games were going to play a central role in the rest of his life. Though he never planned to make it the ...

It was older than the Roman Empire, the Egyptian pyramids and Christianity. Then someone cut it down. Now known as Prometheus, the bristlecone pine tree that found its home on Wheeler Peak in Nevada's ...

A new type of catalyst that uses five times less platinum than usual could help make hydrogen production more affordable in the future. Hydrogen generated by splitting water molecules with electricity ...

Worldwide Clinical Trials is expanding its horizons with the acquisition of Catalyst Clinical Research, a specialist oncology organization with a particular knack for early-stage cancer trials. The ...